LY3127760

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3127760, covering 2019-06-07 to 2019-06-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3127760 in Healthy Participants [Phase 1]